A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

NCT00616434 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Ulcerative Colitis

Interventions

DRUG: BG9418 (Interferon beta-1a)
DRUG: Placebo

Sponsor

Biogen